Clinical trial
A Randomized, Double-blind, Placebo-controlled, Clinical Trial of LY3127804 in Patients Who Are Hospitalized With Pneumonia and Presumed or Confirmed COVID-19
NCT04342897 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-blind, Placebo-controlled, Clinical Trial of LY3127804 in Patients Who Are Hospitalized With Pneumonia and Presumed or Confirmed COVID-19
- Lead sponsor
- Eli Lilly and Company
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- April 20, 2020
- Completion date
- October 12, 2020
- Enrollment
- 95 (actual)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.